Hosted on MSN

New potential drug targets for multiple sclerosis identified

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...
RAPS

Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition

Beginning 23 March, the US Food and Drug Administration (FDA) is going to convert more than 100 medicines approved under new drug applications (NDAs) to biologics license applications (BLAs) because ...
FiercePharma

Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in the form of a safety-related boxed warning. The label update, which also ...
STAT

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Swiss pharma giant Roche won approval from the ...